drugset / Trial / NCT00519675

Alitretinoin in the Treatment of Chronic Hand Eczema

NCT00519675

Phase 3 Completed 150 enrolled Basilea Pharmaceutica
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate the safety and efficacy of alitretinoin in chronic hand eczema that is refractory to topical corticosteroids.

Timeline

Start
2007-05
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject alitretinoin Other / unclassified

Indications